Pulmonary hypertension medical therapy: Difference between revisions

Jump to navigation Jump to search
(New page: {{Pulmonary hypertension}} {{CMG}} '''Assistant Editor(s)-in-Chief:''' Ralph Matar, ==Medical Therapy of Pulmonary Hypertension== ==Overview== Treatment of pulmo...)
 
No edit summary
Line 17: Line 17:
*Decrease the hospitilization rate.
*Decrease the hospitilization rate.
*Improve Survival.
*Improve Survival.
==ESC/ERS Recommendations for General measures==
{{cquote|
===[[ESC/ERS guidelines classification scheme#Classification of Recommendations|Class I]]===
'''1.''' It is recommended to avoid pregnancy in patients with PAH. ''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: A]])''
'''2.''' Immunization of PAH patients against influenza and pneumococcal infections is recommended ''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: A]])''
===[[ACC AHA guidelines classification scheme#Classification of Recommendations|Class IIa]]===
'''1.''' Physically deconditioned PAH patients should be considered for supervised exercise rehabilitation ''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: B]])''
'''2.''' Psychosocial support should be considered in patients with PAH ''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: B]])''
'''3.''' In-flight oxygen administration should be considered for patients in WHO-FC III and IV and those with arterial oxygen pressure consistently less than 60mmHg ''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: B]])''
'''4.''' Epidural anesthesia instead of general anesthesia should be utilised if possible for elective surgery ''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: B]])''
===[[ACC AHA guidelines classification scheme#Classification of Recommendations|Class III]]===
'''1.''' Excessive physical activity that leads to distressing symptoms is not recommended in patients with PAH''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: B]])'}}

Revision as of 18:40, 8 September 2011

Pulmonary Hypertension Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Pulmonary hypertension from other Diseases

Epidemiology & Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History & Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Pulmonary hypertension medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Google Images

American Roentgen Ray Society Images of Pulmonary hypertension medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Pulmonary hypertension medical therapy

CDC on Pulmonary hypertension medical therapy

Pulmonary hypertension medical therapy in the news

Blogs on Pulmonary hypertension medical therapy

Directions to Hospitals Treating Pulmonary hypertension

Risk calculators and risk factors for Pulmonary hypertension medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Assistant Editor(s)-in-Chief: Ralph Matar,

Medical Therapy of Pulmonary Hypertension

Overview

Treatment of pulmonary hypertension has passed through a dramatic evolution in the past few years,in part owing to advances in the understanding of the basic pathophysiological contributors to the disease. However, despite all the modern therapeutic agents, pulmonary hypertension remains a chronic disease with no cure.

Before prescribing any medication, the physician must assess the severity, consider supportive treatment and lifestyle changes, then consider the combination of different drugs and the possibility of further interventions.

Treatment Goals

  • Improving the patient's symptoms.
  • Enhancing functional capacity.
  • Lowering Pulmonary arterial pressure and normalizing cardiac output.
  • Prevent or at least slow the progression of the disease.
  • Decrease the hospitilization rate.
  • Improve Survival.

ESC/ERS Recommendations for General measures

Class I

1. It is recommended to avoid pregnancy in patients with PAH. (Level of Evidence: A)

2. Immunization of PAH patients against influenza and pneumococcal infections is recommended (Level of Evidence: A)


Class IIa

1. Physically deconditioned PAH patients should be considered for supervised exercise rehabilitation (Level of Evidence: B)

2. Psychosocial support should be considered in patients with PAH (Level of Evidence: B)

3. In-flight oxygen administration should be considered for patients in WHO-FC III and IV and those with arterial oxygen pressure consistently less than 60mmHg (Level of Evidence: B)

4. Epidural anesthesia instead of general anesthesia should be utilised if possible for elective surgery (Level of Evidence: B)


Class III

1. Excessive physical activity that leads to distressing symptoms is not recommended in patients with PAH(Level of Evidence: B)'